About Oxyrane UK
Oxyrane UK Limited develops novel and biosuperior versions of enzyme replacement therapies for lysososomal storage diseases using a proprietary glycoengeneering expression host based on the yeast Yarrowia lipolytica. Founded in 2006, the Company is headquartered in Manchester, England.
Facts about Oxyrane UK
Facts about Oxyrane UK
- Focus : Service
- Industry : Biotechnology